October 20, 2017
Taipei, Taiwan
Finnegan cordially invites you to attend an exclusive advanced seminar for biotech and pharmaceutical companies interested in intellectual property law issues.
This program will provide important updates as to legal principles of U.S. patent law and strategies for maximizing your success in obtaining, defending, and licensing patents in the life sciences industry.
Questions will be taken from participants and discussed by the speakers. Lunch will be provided.
Finnegan partners will present on the following topics:
Moderator:
Gary C. Ma
Speakers:
Li Feng
Susan H. Griffen
William L. Strauss
Agenda:
09:00 Registration
09:30 Welcome Remarks & Introduction
09:40 Understanding Current Trends in the Law of Obviousness
10:40 Break
11:00 Licensing Pharmaceutical and Biotechnology Technology – Part I, Instruction
11:40 Lunch
13:15 Greeting
13:20 Licensing Pharmaceutical and Biotechnology Technology – Part II, Workshop
14:40 Break
15:00 IPR Practice Before the PTAB
16:00 Q&A
MCLE Credit:
Finnegan confirms that this activity has been certified for 4.75 hours of California MCLE credit.
Date and Location:
Friday, October 20, 2017
Le Meridien Taipei, Leo Room, 2nd Floor
38, Songren Rd. Xinyi Dist. Taipei 110
台北寒舍艾美酒店 軒轅廳
台北市信義區松仁路38號2樓
Tel: +886-2-6622-8000
RSVP:
Please RSVP by Wednesday, October 18, 2017
For more information, please contact Ms. Nori Chen at
(02)2712-7001 Ext. 113
The event is free of charge. Space is limited to three registrants per company/organization
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.